Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MindWalk Holdings Corp. (HYFT : NSDQ)

• Company Description    MindWalk is a Bio-Native AI company transforming drug discovery and development. MindWalk, formerly known as ImmunoPrecise Antibodies Ltd., is based in AUSTIN, Texas. Number of Employees: 102

• Price / Volume Information    Yesterday's Closing Price: $2.21 Daily Weekly Monthly 20 Day Moving Average: 1,798,899 shares Shares Outstanding: 46.15 (millions) Market Capitalization: $102.00 (millions) Beta: 0.53 52 Week High: $3.25 52 Week Low: $0.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.41% 7.48% 12 Week 118.81% 98.76% Year To Date 436.80% 370.61%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3204-4464 Markham Street - Victoria,A1 V8Z 7X8 CAN ph: 250-483-0308 fax: - investors@immunoprecise.com http://www.immunoprecise.com

• General Corporate Information    Officers Jennifer Bath - Chief Executive Officer Joseph Scheffler - Chief Financial Officer Kari Graber - Vice President Shuji Sato - Vice President Ilse Roodink - Chief Scientific Officer Peer Information MindWalk Holdings Corp. (EVOL) MindWalk Holdings Corp. (RAMP) MindWalk Holdings Corp. (LGTY) MindWalk Holdings Corp. (ALOT) MindWalk Holdings Corp. (CXT) MindWalk Holdings Corp. (TGHI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: 602687105 SIC: 2834 Fiscal Year Fiscal Year End: April Last Reported Quarter: 04/01/25 Next Expected EPS Date: 09/15/25 Share - Related Items Shares Outstanding: 46.15 Most Recent Split Date: (:1) Beta: 0.53 Market Capitalization: $102.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.04 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/15/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.02 Price/Cash Flow: - Price / Sales: 5.80 EPS Growth vs. Year Ago Period: 92.31% vs. Previous Quarter: 33.33% Sales Growth vs. Year Ago Period: 3.24% vs. Previous Quarter: 13.47% ROE 07/31/25 - - 04/30/25 - -40.62 01/31/25 - -88.87 ROA 07/31/25 - - 04/30/25 - -22.19 01/31/25 - -49.26 Current Ratio 07/31/25 - - 04/30/25 - 2.08 01/31/25 - 2.32 Quick Ratio 07/31/25 - - 04/30/25 - 1.85 01/31/25 - 2.11 Operating Margin 07/31/25 - - 04/30/25 - -47.69 01/31/25 - -115.69 Net Margin 07/31/25 - - 04/30/25 - -122.10 01/31/25 - -190.76 Pre-Tax Margin 07/31/25 - - 04/30/25 - -139.75 01/31/25 - -211.85 Book Value 07/31/25 - - 04/30/25 - 0.37 01/31/25 - 0.57 Inventory Turnover 07/31/25 - - 04/30/25 - 5.53 01/31/25 - 5.94 Debt-to-Equity 07/31/25 - - 04/30/25 - 0.49 01/31/25 - 0.45 Debt-to-Capital 07/31/25 - - 04/30/25 - 32.84 01/31/25 - 30.91

Powered by Zacks Investment Research ©